FDA Adverse Event Malfunction Summary report: N

AXSYM CMV IGG REAGENT

MDR report key: 2111883 · Received June 2, 2011

Report

Report Number
1415939-2011-00165
Event Type
Malfunction
Date Received
June 2, 2011
Date of Event
June 23, 2010
Report Date
March 28, 2011
Manufacturer
ABBOTT LABORATORIES
Product Code
LFZ
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

FURTHER INVESTIGATION OF THE CUSTOMER ISSUE INCLUDED A REVIEW OF THE COMPLAINT TEXT, IN HOUSE TESTING, A SEARCH FOR SIMILAR COMPLAINTS, AND A REVIEW OF LABELING. THREE AXSYM INSTRUMENTS WERE CALIBRATED PER THE INSTRUCTIONS IN THE PACKAGE INSERT BY TESTING THE CALIBRATORS IN DUPLICATE WITH REAGENT LOT 92966M500. FOR EACH OF THE THREE RUNS, A SINGLE REPLICATE OF EACH LEVEL OF ABBOTT CONTROLS WAS TESTED PER THE PACKAGE INSERT FOR VALIDITY. FIVE REPLICATES OF EACH AXSYM CMV-G PANELS 1, 2 AND 3 WERE TESTED ACROSS ALL THREE INSTRUMENTS. THE ACCEPTANCE CRITERIA WERE MET. TRACKING AND TRENDING IDENTIFIED NO ADVERSE TREND. LABELING WAS REVIEWED AND FOUND TO BE ADEQUATE. BASED ON THE INVESTIGATION, NO DEFICIENCY WAS IDENTIFIED.

Additional Manufacturer Narrative · 1

(B)(4). THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, (B)(4), THAT HAS A SIMILAR US PRODUCT DISTRIBUTED IN THE US, (B)(4). A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE INVESTIGATION IS COMPLETE. AN INVESTIGATION IS IN PROCESS.

Description of Event or Problem · 1

THE CUSTOMER STATED AN AXSYM ANALYZER GENERATED FALSE (B)(6) CMV IGG RESULTS FOR THREE SAMPLES DRAWN FROM THE SAME PATIENT OVER A PERIOD OF NINE MONTHS. AN ARCHITECT ANALYZER GENERATED (B)(6) CMV IGG RESULTS FOR THE SAME PATIENT. THE (B)(6) CMV IGG RESULTS WERE CONFIRMED BY A (B)(4). THERE WAS NO ADVERSE IMPACT TO PATIENT MANAGEMENT REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 AXSYM CMV IGG REAGENT FOR THE MEASUREMENT OF IGG ANTIBODIES TO CYTOMEGALOVIRUS LFZ ABBOTT LABORATORIES

Patients

Seq Age Sex Outcome Treatment
1 AXSYM LN 7A83-85 (B)(4)| AXSYM LN 7A83-85 (B)(4)